Paper
0
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Authors
Carolyn Bramante,Jared Huling
Christopher Tignanelli,John Buse,David Liebovitz,Jacinda Nicklas,Kenneth Cohen,Michael Puskarich,Hrishikesh Belani,Jennifer Proper,Lianne Siegel,Nichole Klatt,David Odde,Darlette Luke,Blake Anderson,Amy Karger,Nicholas Ingraham,Katrina Hartman,Via Rao,Aubrey Hagen,Barkha Patel,Sarah Fenno,Nandini Avula,Neha Reddy,Spencer Erickson,Sarah Lindberg,Regina Fricton,Samuel Lee,Adnin Zaman,Hanna Saveraid,Walker Tordsen,Matthew Pullen,Michelle Biros,Nancy Sherwood,Jennifer Thompson,David Boulware,Thomas Murray
+35 authors
,Robert JefferyPublished
Aug 17, 2022
Show more
Save
Tip0
TipSave
Abstract
Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.